Methyl-CCNU in Malignant Melanoma – A Divided Dose Schedule of Administration
作者:
R.E. Wittes,
Ki Hong,
Linda Gatchell,
I.H. Krakoff,
R.B. Golbey,
期刊:
Oncology
(Karger Available online 1977)
卷期:
Volume 34,
issue 1
页码: 45-46
ISSN:0030-2414
年代: 1977
DOI:10.1159/000225178
出版商: S. Karger AG
关键词: Methyl-CCNU;Melanoma;Myelosuppression
数据来源: Karger
摘要:
Methyl-CCNU (NSC-95441) was administered to patients with malignant melanoma in a split dose schedule. Nausea and vomiting were eliminated as clinical problems during therapy. Response rate to the drug seemed somewhat lower than the average of three previously reported disease-oriented phase II trials, though the difference was not significant statistically. The time course of myelosuppression seemed comparable to that seen with a single dose schedule of administration.
点击下载:
PDF
(848KB)
返 回